Haemodialysis as a means of saving the lives of patients suffering from chronic renal failure is an every day event. The problems arising in some cases were not, however, realised until the first publication by Howell and Perkins in 1972 ,1 which has since been followed by several others. [2] [3] [4] [5] [6] [7] [8] The problems at first seemed to be merely serological, causing some inconvenience to the blood bank laboratory trying to find units of blood compatible with the patient's unexpectedly produced antibodies. Since then the scope of the problem has widened and become an immunological one.
Howell and Perkins' first After that the red cells were washed three times, or until supernatant was no longer haemolytic, and resuspended into a 50 suspension.
The sera were tested for the presence of anti OMF (anti-F) as well as for anti-N-like antibodies by incubating equal volumes-that is, two drops of serum with two drops of a 500 suspension of red cells for 30 minutes at room temperature and the reaction was determined after 30 seconds' spin at 3400 rpm in a Clay Adams serofuge. The strength of the reaction varied from 1+ to 4+. Absorptions were performed at room temperature since this was optimal for both antibodies detected.
Tests applying sheep red cells were performed only after the patient's serum was absorbed with normal sheep red cells. Treatment of sheep red cells with formaldehyde was the same as the treatment of human red cells.
Results
The sera of 25 patients undergoing chronic haemodialysis (two to three times a week) were tested for the presence of anti-F as well as for the presence of anti-N-like antibodies. All sera that reacted with OMF cells were also titrated with the same cells. To determine the sequence of the production of the two antibodies all sera were tested, beginning with samples collected in 1975 up to the present. Eight typical samples are shown in the Table. As can be seen, no anti-N-like antibodies were detected so long as there was either no anti-F activity or until the titre of anti-F was above 64 or 128.
The relationship or interdependence of the antibodies was determined by absorption experiments. This sequence can be explained by our previous work10 11 describing two events related to the presence of traces of formaldehyde in the dialysis units that affects both the antigenicity of the red cells and the antibody response to various antigens.12 We assume that production of antibody begins only after the prolonged stimulation of the immune system by the F-altered red cells, or possibly it may start long before it can be detected. It is clearly a true antibody because of its specific reaction with monospecific anti-IgG serum.'0 The fact that the antibodies reacting with the formalin-treated red cells are IgG antibodies and yet the reaction takes place at room temperature, and the fact that the reaction occurs within five minutes or less probably indicate that the formaldehyde neutralises the negative charge of the red cells. This could explain why the IgG antibodies are able to cause direct agglutination without the aid of antiglobulin serum. Anti-N-like antibodies, if they are antibodies, seem to be a late appendix to the anti-F antibodies, which Relationship between formaldehyde-related antibodies and cross-reacting anti-N-like antibodies 43
The most probable explanation for the production of two distinct antibodies resulting from the use of formaldehyde resterilisable dialysis membranes is that the immune response of the patient is triggered by a formaldehyde alteration of a protein which is familiar yet not identical with the glycoprotein that defines the M and N antigens. As a result, antibodies are first formed against this new immunogen (formalin-altered protein). On further contact with that protein the titre of the antibodies rises yet the specificity of the antibody is lowered and it starts cross-reacting with the native N antigen to form the second antibody, the anti-N-like antibody.
There has as yet been no report of an autoimmune haemolytic anaemia related to autoanti-N-like antibodies-which is what these antibodies in most cases are, since anti-N-like antibodies were found in homozygous NN patients as well as heterozygous MN.9 Further investigations will have to be performed in animals to establish the relationship between the production of anti-F and the apparent 'autoantibody', so far termed anti-N-like antibody.
The fact that formalin-treated sheep red cells absorb an anti-F activity present in the serum indicates that the anti-F activity is not speciesspecific, so that the change caused by formaldehyde to a protein constituent of the red cell membrane must be specific for the red cell yet not a human specific antigen. 
